The FDA has broadened the scope of Xolair, a medication used for asthma, to now include treatment for severe food allergies.
The U.S. Food and Drug Administration announced on Friday that a medication typically prescribed for asthma can now be utilized to assist individuals with food allergies in preventing severe reactions. The medication omalizumab, sold under the brand name Xolair, was granted approval to decrease allergic responses triggered by accidental ingestion of food. People as young
READ MORE